chemotherapy calculation - YouTube
Paclitaxel exposure-toxicity analysis reveals a pharmacokinetic determinant for dose-limiting neutropenia in East-Asian solid tumor patients: results from two prospective, phase II studies | SpringerLink
Effect of body mass index on pharmacokinetics of paclitaxel in patients with early breast cancer - Gota - 2021 - Cancer Medicine - Wiley Online Library
Randomized study of individualized pharmacokinetically‐guided dosing of paclitaxel compared with body‐surface area dosing in Chinese patients with advanced non‐small cell lung cancer - Zhang - 2019 - British Journal of Clinical Pharmacology -
EU Dosing App APK for Android Download
PDF) How to calculate the dose of chemotherapy
8. Calculation of Doses- Patient Parameters.ppt [相容模式]
PDF) How to calculate the dose of chemotherapy
Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer | Journal for ImmunoTherapy of Cancer
160-Breast adjuvant PACLitaxel dose dense | eviQ
A Dose Finding Study of Weekly and Every-3-Week nab-Paclitaxel Followed by Carboplatin as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer - ScienceDirect
PDF) Overestimation of carboplatin doses is avoided by radionuclide GFR measurement
Randomized study of individualized pharmacokinetically‐guided dosing of paclitaxel compared with body‐surface area dosing in Chinese patients with advanced non‐small cell lung cancer - Zhang - 2019 - British Journal of Clinical Pharmacology -
EU Dosing App APK for Android Download
Paclitaxel | CAS:33069-62-4 | Antineoplastic agent | Diterpenoids | High Purity | Manufacturer BioCrick
Paclitaxel | C47H51NO14 - PubChem
PDF) Standardization and Scoring of the Body Surface Area (BSA) Formulas for Calculation of the Doses of Anticancer Agents for Cancer Patients from the North-Western Nigeria
Calculations of Doses
Bioline International Official Site (site up-dated regularly)
Paclitaxel-Carboplatin with dose dense EC Neoadjuvant Regimen
Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents | British Journal of Cancer
